Quest Diagnostics (DGX) reported earnings on Tue 24 July 2018 (b/o)

**  before earnings **

** charts after earnings **

 

Quest Diagnostics misses by $0.01, misses on revs; guides FY18 EPS below consensus, revs in-line

• Reports Q2 (Jun) earnings of $1.75 per share, excluding non-recurring items, $0.01 worse than the Capital IQ Consensus of $1.76; revenues rose 3.0% year/year to $1.92 bln vs the $1.95 bln Capital IQ Consensus.
• Co issues guidancefor FY18, sees EPS of $6.53-6.57, excluding non-recurring items, vs. $6.61 Capital IQ Consensus Estimate and prior guidance of $6.50-6.70; sees FY18 revs of $7.70-7.74 bln vs. $7.72 bln Capital IQ Consensus Estimate and prior guidance of $7.70-7.77 bln.